BA (hons), BMBCh (hons), MRCP, DPhil (Oxon)
Associate Professor of Cardiovascular Medicine
- British Heart Foundation Intermediate Clinical Research Fellow
- Deputy Clinical Director of OCMR
- Honorary Consultant Cardiologist
After studying medicine at Pembroke College (1996-2002) I completed the Royal College Examinations and specialized in Cardiology. In 2005 I was awarded a Wellcome Trust Junior Research Fellowship to complete my DPhil in Cardiovascular medicine at Oxford, where I used advanced cardiac magnetic resonance imaging and spectroscopy to study the effects of obesity and weight loss on myocardial metabolism and function. For this work I was awarded the American Heart Association Young Investigator Award for Nutrition Physical Activity and Metabolism (2008) and took up the role of Clinical Lecturer in Cardiovascular Medicine in Oxford in 2010 where I furthered my research into obesity. In 2015 I was appointed as an Honorary Consultant Cardiologist and Deputy Clinical Director or the University of Oxford Centre for Clinical Magnetic Resonance Research. I currently hold a British Heart Foundation Intermediate Clinical Research Fellowship and run a research group that uses advanced cardiac magnetic resonance imaging and spectroscopy to investigate the relationship between cardiac substrate metabolism, cardiac energetics and cardiac function in multiple diseases with a focus on obesity, bariatric surgery, heart failure and cardiac hypertrophy.
Hyperpolarised magnetic resonance for in vivo real-time metabolic imaging.
Apps A. et al, (2018), Heart
Noninvasive Immunometabolic Cardiac Inflammation Imaging Using Hyperpolarized Magnetic Resonance.
Lewis AJM. et al, (2018), Circ Res, 122, 1084 - 1093
The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity.
Rayner JJ. et al, (2018), Int J Obes (Lond), 42, 441 - 447
The Physiological, Pathological and Molecular Basis of Nonalcoholic Steatohepatitis Associated Cardiomyopathy
Oseini A. et al, (2017), HEPATOLOGY, 66, 1086A - 1086A
Nonalcoholic Steatohepatitis (NASH) Impairs Ventricular Diastolic Distensibility And Function Independent Of Underlying Type 2 Diabetes Or Hypertension
Siddiqui M. et al, (2017), HEPATOLOGY, 66, 1137A - 1137A